Publications by authors named "Jochen Salfeld"

Claim this Profile
A
Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Felicia M Bloemendaal, Alon D Levin, Manon E Wildenberg, Pim J Koelink, Bradford L McRae, Jochen Salfeld

Gastroenterology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease.
Bradford L McRae, Alon D Levin, Manon E Wildenberg, Pim J Koelink, Peter Bousquet, Jochen Salfeld

J Crohns Colitis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of antibodies using single-open reading frame vector design and polyprotein processing from mammalian cells.
Yune Z Kunes, Wendy R Gion, Emma Fung, Jochen G Salfeld, Rong-Rong Zhu

Biotechnol Prog· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.
Zehra Kaymakcalan, Paul Sakorafas, Sahana Bose, Susanne Scesney, Limin Xiong, Jochen Salfeld

Clin Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.
Daniel Tracey, Lars Klareskog, Eric H Sasso, Jochen G Salfeld, Paul P Tak

Pharmacol Ther· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biotechnology era: has the promise been fulfilled?
Jochen G Salfeld

Expert Opin Drug Discov· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotype selection in antibody engineering.
Jochen G Salfeld

Nat Biotechnol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview on the use of therapeutic antibodies in drug discovery.
Michael Roguska, Zehra Kaymakcalan, Jochen Salfeld

Curr Protoc Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-12 antibody for active Crohn's disease.
Peter J Mannon, Ivan J Fuss, Lloyd Mayer, Charles O Elson, William J Sandborn, Jochen Salfeld

N Engl J Med· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of new biotechnology to design rational drugs against newly defined targets.
Jochen G Salfeld

Best Pract Res Clin Rheumatol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis